Vident Advisory’s Alkermes ALKS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.97M Buy
84,090
+1,796
+2% +$55.7K 0.03% 506
2025
Q4
$2.3M Buy
82,294
+864
+1% +$25.9K 0.02% 528
2025
Q3
$2.44M Buy
81,430
+21,854
+37% +$616K 0.02% 507
2025
Q2
$1.7M Buy
59,576
+2,759
+5% +$82.1K 0.02% 554
2025
Q1
$1.88M Sell
56,817
-9,314
-14% -$304K 0.03% 500
2024
Q4
$1.9M Sell
66,131
-2,753
-4% -$79.1K 0.03% 429
2024
Q3
$1.93M Buy
+68,884
New +$1.84M 0.05% 395

Other funds holding ALKS

Vident Advisory's ALKS Position: Q1 2026 in Review

Vident Advisory increased its Alkermes (ALKS) stake by 2.2% in Q1 2026, buying an estimated $55.7K and bringing the position to 84,090 shares worth $2.97M. The position accounts for 0.03% of the portfolio, ranked #506.

Vident Advisory first reported a position in ALKS in Q3 2024 and has held it in 7 quarters since. 388 funds tracked by Wall St. Rank hold ALKS as of Q1 2026.

  • Vident Advisory held 84,090 shares of Alkermes worth $2.97M as of Q1 2026.
  • Vident Advisory bought 1,796 Alkermes shares in Q1 2026, an estimated $55.7K.
  • Alkermes made up 0.03% of Vident Advisory's portfolio in Q1 2026, its #506 holding.
  • Vident Advisory first reported a position in Alkermes in Q3 2024 and has held it in 7 quarters since.
  • 388 funds tracked by Wall St. Rank held Alkermes as of Q1 2026.

Based on Vident Advisory's 13F filing for Q1 2026, filed 15 May 2026.